In-vitro and in-vivo models for hepatitis B cure research - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Current Opinion in HIV and AIDS Année : 2020

In-vitro and in-vivo models for hepatitis B cure research

Résumé

Antiviral therapy for chronic hepatitis B infection is rarely curative, thus research in HBV cure strategies is a priority. Drug development and testing has been hampered by the lack of robust cell culture systems and small animal models. This review summarizes existing models for HBV cure research and focuses on recent developments since 2017 until today.

Domaines

Virologie
Fichier non déposé

Dates et versions

pasteur-02875586 , version 1 (19-06-2020)

Identifiants

Citer

Lena Allweiss, Helene Strick-Marchand. In-vitro and in-vivo models for hepatitis B cure research. Current Opinion in HIV and AIDS, 2020, 15 (3), pp.173-179. ⟨10.1097/COH.0000000000000616⟩. ⟨pasteur-02875586⟩

Collections

PASTEUR ATP-IMMUN
48 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More